Breast Cancer
Right Breast Carcinoma
Female, 42 years
Patient Internal ID: 424408
ICD-10 code
C50.2 Malignant Neoplasm of Upper-inner Quadrant of Breast
Diagnosis (Incl. Metastases/Stage) and Year
April 2022
Right Breast Carcinoma pT1cN0M0 G3 ER(+), PR(-), HER2(-), LVI-1, R0, Ki67-60% Stage IA.
Previous Treatment
Surgery, Chemotherapy (Paclitaxel), Radiation Therapy, Hormone Therapy (Tamoxifen).
Prognosis and Survival Expectation
The prognosis for Localized Hormone Sensitive Breast Cancer is good, with a relative 5-year survival rate up to 95%.
Treatment Provided
Autologous DCV (7 doses) and CIK (8 doses) over a period of 9 months. Additionally, the patient received Immunostimulation of Interferon (IFN) β and Tumor Necrosis Factor (TNF) as well as Mistletoe Therapy.
Patient Survival/Condition and Year
Date of Review: 25/11/2023
The patient is alive, has a stable disease and no sign of disease progression. She continues hormonal treatment with Tamoxifen and is attending regular check-ups.
